Drive out Polymyalgia Rheumatica with Worldwide Clinical Trials

People suffering with polymyalgia rheumatica may get a good night’s sleep, but they rarely feel good in the morning. The condition inflames the linings of the joints in their backs, necks, shoulders, or hips. They feel stiff after resting, and movement can be so painful that some people can’t get out of bed.

Polymyalgia rheumatica mostly affects women over the age of 55, though it also can affect men of a similar age. Its cause is unknown, and diagnosis usually follows a physical examination and one or more blood tests. Although most individuals with polymyalgia rheumatica respond quickly to a treatment regimen of corticosteroids, such as prednisone, this treatment can have its own side effects and create further problems.

If your research focuses on finding better therapies for treating – or even preventing – polymyalgia rheumatica, one thing that stands between you and the marketplace is the clinical trial phase. Where will you find people willing to participate in the trial of your therapy? How will you find healthcare facilities where your work can be put to the test? What about clinicians qualified to help you put your work to the test?

That’s why you need Worldwide Clinical Trials. We are internationally acclaimed experts in clinical trial management, with more than 30 years of experience supporting research into immune-mediated inflammatory disorders (IMID). We offer full-service support for Phase I-Phase IV clinical trials, as well as real-world evidence studies that can help you understand the effects of your work over both the short and long term. We also have relationships with healthcare facilities and clinicians in more than 60 countries, so we are singularly well positioned to help you conduct your trials; capture the critical research data; and move your project forward quickly, efficiently, and safely.

When it’s time to take that next step, call Worldwide.